Switching Therapies in Multiple Sclerosis

被引:0
|
作者
Patricia K. Coyle
机构
[1] Stony Brook University Medical Center,Department of Neurology
来源
CNS Drugs | 2013年 / 27卷
关键词
Multiple Sclerosis; Multiple Sclerosis Patient; Progressive Multifocal Leukoencephalopathy; Natalizumab; Glatiramer Acetate;
D O I
暂无
中图分类号
学科分类号
摘要
There are currently nine approved disease modifying therapies for relapsing forms of multiple sclerosis, with six distinct mechanisms of action. All have side effects, and none are cures. When a patient cannot tolerate therapy, or there is unacceptable breakthrough disease activity, the most common approach is to change drug. No universal guidelines exist for switching therapy. This overview will propose switch principles and suggestions.
引用
收藏
页码:239 / 247
页数:8
相关论文
共 50 条
  • [1] Switching Therapies in Multiple Sclerosis
    Coyle, Patricia K.
    [J]. CNS DRUGS, 2013, 27 (04) : 239 - 247
  • [2] Switching From Natalizumab To Immune Reconstitution Therapies In Patients With Multiple Sclerosis
    Matos, Sara
    Cunha, Carolina
    Bernardes, Catarina
    Cardoso, Joao
    Campelo, Isabel
    Feio, Jose
    Batista, Sonia
    Nunes, Carla
    Macario, Maria do Carmo
    Sousa, Livia Maria
    Correia, Ines
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 931 - 931
  • [3] Therapies in multiple sclerosis
    Comi, G.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 829 - 829
  • [4] Efficacy of switching disease-modifying therapies on walking in persons with multiple sclerosis
    Ozakbas, Serkan
    Ozdogar, Asiye Tuba
    Abasiyanik, Zuhal
    Ertekin, Ozge
    Kahraman, Turhan
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (07) : 1051 - 1051
  • [5] Switching disease modifying therapies in multiple sclerosis patients: a study of 110 patients
    Morra, VB
    Coppola, G
    Lanzillo, R
    Vacca, G
    Pagano, A
    Orefice, G
    [J]. MULTIPLE SCLEROSIS, 2004, 10 (7032): : S235 - S235
  • [6] MULTIPLE SCLEROSIS Switching sides-fingolimod versus injectable MS therapies
    Rossman, Ian T.
    Cohen, Jeffrey A.
    [J]. NATURE REVIEWS NEUROLOGY, 2015, 11 (06) : 316 - 317
  • [7] Audit of patients switching disease-modifying therapies for the treatment of multiple sclerosis
    Embrey, NH
    Woolmore, JA
    Hawkins, CP
    [J]. MULTIPLE SCLEROSIS, 2005, 11 : S159 - S159
  • [8] Switching disease modifying therapies in multiple sclerosis patients: a study on 110 patients
    Morra, VB
    Coppola, G
    Vacca, G
    Longobardi, M
    Ascione, S
    Schiavone, V
    Pagano, A
    Bonavita, V
    Orefice, G
    [J]. JOURNAL OF NEUROLOGY, 2004, 251 : 88 - 88
  • [9] Switching disease-modifying therapies in multiple sclerosis patients: A study on 110 patients
    Morra, V. Brescia
    Coppola, G.
    Vacca, G.
    Longobardi, M.
    Ascione, S.
    Schiavone, V.
    Pagano, A.
    Bonavita, V.
    Orefice, G.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 263 - 264
  • [10] Evolving therapies for multiple sclerosis
    Korniychuk, Elena
    Dempster, John M.
    O'Connor, Eileen
    Alexander, J. Steven
    Kelley, Roger E.
    Kenner, Meghan
    Menon, Uma
    Misra, Vivek
    Hoque, Romy
    Gonzalez-Toledo, Eduardo
    Schwendimann, Robert N.
    Smith, Stacy
    Minagar, Alireza
    [J]. NEUROBIOLOGY OF MULTIPLE SCLEROSIS, 2007, 79 : 571 - 588